CD4 and neoplasm: Recently, Saito et al., have proposed a model with two different populations of CD4+FOXP3+ cells in CRC, suppressive FOXP3high Treg and FOXP3low non-suppressive effector T cells, and that the balance between the two subsets determine tumor progression [16].